|
Gestational Trophoblastic Neoplasia (GTN) Education Module |
|
Enduring |
|
$15.00 |
|
HER2 Testing in Gynecologic Cancers and Implications for Treatment |
|
Enduring |
|
$0.00 |
|
Highlights from ESMO 2025 |
|
Enduring |
|
$0.00 |
|
Highlights from the SGO 2023 Annual Meeting on Women's Cancer |
|
Enduring |
|
$195.00 |
|
Highlights from the SGO 2024 Annual Meeting on Women's Cancer |
|
Enduring |
|
$195.00 |
|
HIPEC in Gynecologic Oncology: State of the science and a practical how to On-Demand Webinar |
|
Enduring |
|
$35.00 |
|
Insurance Appeal Resources |
|
Enduring |
|
$0.00 |
|
Is Urology in the House? Practical Management of Urologic Complications in Common Gyn Oncology Procedures On-Demand Webinar |
|
Enduring |
|
$35.00 |
|
Leave No Patient Behind: Progress Towards Equity (2023 Annual Meeting) |
|
Enduring |
|
$0.00 |
|
Management of Chemotherapy Hypersensitivity Reactions and Desensitization: An SGO Clinical Practice Statement |
|
Enduring |
|
$0.00 |
|
Molecular Target: Folate Receptor Alpha (FOLR1) |
|
Enduring |
|
$0.00 |
|
Molecular Target: Human Epidermal Growth Factor Receptor 2 (HER2) |
|
Enduring |
|
$0.00 |
|
Navigating High Stakes Conversations in Gynecologic Oncology |
|
Enduring |
|
$0.00 |
|
New Drugs, New Problems: Managing Toxicities Session (2023 Annual Meeting) |
|
Enduring |
|
$0.00 |
|
Ocular Toxicities with ADCs Companion Card |
|
Enduring |
|
$0.00 |
Facebook
X
LinkedIn
Forward